Several healthcare and biotech stocks posted notable gains in after-hours trading on Monday, driven by earnings updates, executive appointments, and capital market activity.Pulmonx Corp. (LUNG) surged 33.33% to $2.08 as of 9:36 PM EDT. The company announced preliminary, unaudited third-quarter 2025 revenue of about$21.5 million. Pulmonx also rescheduled its Q3 financial results release to Wednesday, November 12, 2025, after market close. In a leadership update, Glen French was reappointed as President and ...